Sign In
Buy STVN
$19.85
-0.350 (-1.73%)
At Close: Jul 31, 2026
STVN or MDGL: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 26'th Jan 2026
Investors looking for stocks in the Medical - Drugs sector might want to consider either Stevanato Group (STVN) or Madrigal (MDGL). But which of these two stocks offers value investors a better bang f
Stevanato Group S.p.A. (NYSE:STVN) Given Consensus Rating of “Moderate Buy” by Brokerages
03:22am, Saturday, 24'th Jan 2026
Shares of Stevanato Group S.p.A. (NYSE: STVN - Get Free Report) have been given an average recommendation of "Moderate Buy" by the five brokerages that are currently covering the company, MarketBeat.c
Datwyler, LTS Device Technologies, and Stevanato Group Collaborate to Expand Self-Delivery Options for Large-Volume Drugs
05:05am, Friday, 16'th Jan 2026
/PRNewswire/ -- Datwyler (Middletown, Delaware) a leading provider of high-value, system-critical elastomer components, announced a collaboration with LTS
Stevanato: Structural Growth Intact, Buy Confirmed
12:10pm, Saturday, 03'rd Jan 2026
Stevanato's biologics remain the core growth engine supported by a broad pipeline, resilient GLP-1 demand, vial recovery, and a favorable industry backdrop. While Engineering continues to weigh on mar
SDZNY vs. STVN: Which Stock Is the Better Value Option?
12:41pm, Friday, 19'th Dec 2025
Investors interested in Medical - Drugs stocks are likely familiar with Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two stocks presents investors with the bett
SDZNY vs. STVN: Which Stock Should Value Investors Buy Now?
12:41pm, Wednesday, 03'rd Dec 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Stevanato Group (STVN). But which of these two companies is the best o
Stevanato Group S.p.A. (STVN) Q3 2025 Earnings Call Transcript
03:06am, Friday, 07'th Nov 2025
Stevanato Group S.p.A. ( STVN ) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants Lisa Miles - Chief Communications & Investor Relations Officer Franco Stevanato - CEO & Executiv
Stevanato Group (STVN) Q3 Earnings and Revenues Surpass Estimates
08:46am, Thursday, 06'th Nov 2025
Stevanato Group (STVN) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.13 per share a year ago.
Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025
06:30am, Thursday, 06'th Nov 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
SDZNY vs. STVN: Which Stock Is the Better Value Option?
01:51pm, Friday, 31'st Oct 2025
Investors interested in Medical - Drugs stocks are likely familiar with Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two companies is the best option for those
Stevanato Group to Participate in Upcoming Investor Conferences
07:30am, Friday, 31'st Oct 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025
06:30am, Wednesday, 22'nd Oct 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology,
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings
06:30am, Tuesday, 21'st Oct 2025
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology a
GRFS vs. STVN: Which Stock Should Value Investors Buy Now?
12:41pm, Friday, 10'th Oct 2025
Investors looking for stocks in the Medical - Drugs sector might want to consider either Grifols (GRFS) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang fo
Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2025 Transcript
09:23am, Wednesday, 24'th Sep 2025
Stevanato Group S.p.A. (NYSE:STVN ) Bank of America Global Healthcare Conference 2025 September 24, 2025 5:45 AM EDT Company Participants Marco Dal Lago - Chief Financial Officer Conference Call Parti
